CRMD Cormedix Inc

Cormedix Inc is a commercial-stage biopharmaceutical company. It focuses on development and commercializing prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases.

$4.63  -0.10 (-2.11%)
As of 12/06/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/13/2010
Outstanding shares:  38,086,437
Average volume:  191,815
Market cap:   $180,148,847
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    21900C308
ISIN:        US21900C3088
Sedol:      BJ0LT31
Valuation   (See tab for details)
PE ratio:   -6.65
PB ratio:   2.54
PS ratio:   946.89
Return on equity:   -38.22%
Net income %:   -13,932.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy